This first episode explores how people who have been affected by hepatitis C are leading the fight against the virus in their communities. Sarah Jarvis, our host, is joined by Cary James of the World Hepatitis Alliance, Professor Carla Treloar from the University of New South Wales and Tony McClure from the Hepatitis C Trust. Job code: IHQ-HCV-2020-10-0001Date of preparation: May 2022

S1 #1 Engagement

“I was nervous being a first-time mum, but also about potentially passing hepatitis B to my child” says Nafisa Yussf, a Hepatitis Community Advocate living with hepatitis B in Australia.&nbsp;In this first episode of series 2, Dr Sarah Jarvis is joined by Nafisa Yussf and two other passionate women: Cynthia Raissa Tamandjou, a Medical Virologist based in France and Bisi Bright, a Clinical Pharmacist and CEO of the LiveWell Initiative in Nigeria. These inspiring women have dedicated their lives to empowering women and mothers living with viral hepatitis, challenging misconceptions and tackling the stigma to improve the lives of others.&nbsp;&nbsp;&nbsp;The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.&nbsp;Job bag number: IHQ-UNB-1415&nbsp;Date of preparation: April 2022&nbsp;&nbsp;

S2 #1 Women Leading the Fight to Protect the Next Generation from Hepatitis

In Series Two of the Hep-cast we will focus on the lives of those impacted by viral hepatitis globally, including mothers, young people, people who have been incarcerated, refugees and migrants. The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited. Job bag number: IHQ-UNB-1408Date of preparation: May 2022

Series 2 Trailer

In this season's final episode, our panel discusses the power of the global hepatitis movement and their willingness to achieve the elimination of viral hepatitis as a public health threat, including how to overcome the challenges that lie ahead. Our host, Dr Sarah Jarvis, is joined by Charles Gore, hepatitis advocate and founder of the World Hepatitis Alliance (WHA), Dr Su Wang, President of the WHA, Homie Razavi, MD of Center for Disease Analysis Foundation, and John Ward, Director of the Coalition for Global Hepatitis Elimination at the Task Force for Global Health.The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.Job bag number: IHQ-HCV-2020-12-0015Date of preparation: May 2022

S1 #7 The Global Movement to Eliminate Viral Hepatitis

This episode speaks to three women whose organisations are working together to achieve the elimination of hepatitis C in their community. Our host, Dr Sarah Jarvis, is joined by Shabana Begum, the South Asian Project Officer at The Hepatitis C Trust, Stacey Smith, Director of Nursing at Humankind and Diane Williams, Hepatitis C Network Manager for the West Yorkshire Operational Delivery Network. The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited. Job code: IHQ-HCV-2020-10-0077Date of preparation: May 2022

S1 #6 UK in Focus: Collaborate to Eliminate

In the first of our two ‘UK in Focus’&nbsp;episodes,&nbsp;our&nbsp;panel&nbsp;discusses the&nbsp;current status&nbsp;of&nbsp;hepatitis C elimination in the UK&nbsp;and share&nbsp;good practice initiatives that are making elimination possible.&nbsp;Our host, Dr Sarah Jarvis, is joined by&nbsp;Professor Graham Foster, Professor of Hepatology at Queen Mary University of London, Rachel Halford, CEO&nbsp;of&nbsp;the Hepatitis C Trust and Professor John Dillon, Professor of Hepatology and Gastroenterology at University of Dundee.&nbsp; The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.Job bag IHQ-HCV-2020-10-0073Date of preparation: May 2022

S1 #5 UK in Focus: Elimination is Possible

This episode focuses on the role of harm reduction services in protecting vulnerable people from hepatitis C. Host Sarah Jarvis hears from Heidi Fridriksdottir, Project Manager of the TrapHepC initiative in Iceland – where they have already reached the WHO service targets for hepatitis C elimination –, Aura Roig, Director of the grass-roots, women-focussed Metzineres organization in Barcelona and Jodie Albert, a Community Outreach Worker in the Atahkakoop Know Your Status hepatitis C program, a rural First Nation community in Canada. The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.Job bag: IHQ-HCV-2020-10-0031Date of preparation: May 2022

S1 #4 Ending the chain of transmission

In this episode our focus turns to treatment as we explore the power of cure and how to successfully take treatment to the people who need it most. Host Sarah Jarvis is joined by Maka Gogia, Program Director of the Georgian Harm Reduction Network, George Kalamitsis, Chair of the Hellenic Liver Patient Association in Athens and Alex Thompson, Director of Gastroenterology at St Vincent’s Hospital in Melbourne.&nbsp; The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited. Job code: IHQ-HCV-2020-10-0084Date of preparation: May 2022

S1 #3 Breaking Barriers to Treatment

This second episode focusses on testing and how finding the ‘missing millions’ is essential to eliminate hepatitis C. Our host, Dr Sarah Jarvis, is joined by Manal El Sayed from the Egyptian National Committee for the Control of Viral Hepatitis, Sonjelle Shilton, Deputy Head of HCV access at Global NGO FIND and Jennifer Slepin, who co-founded HepCarestream in the USA after being cured of hepatitis C. The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.&nbsp;Job code: IHQ-HCV-2020-10-0029 Date of preparation: May 2022

S1 #2 Finding the Missing Millions

The real-life stories behind the fight to eliminate viral hepatitis

Join us as we go beyond the statistics to explore the human impact of one of the greatest health crises of our time. Over 350 million people are living with viral hepatitis worldwide. The Hep-cast is about the people whose lives have been changed by viral hepatitis and those fighting to eliminate it as a public health threat by 2030. Guests include people living with viral hepatitis, healthcare professionals, policymakers, and activists. They will expose the human cost of this cruel virus and explore what can be done to win the fight against it. The Hep-cast is a collaboration between the World Hepatitis Alliance and Gilead Sciences. The Hep-cast is fully funded by Gilead Sciences Europe Limited.

The Hep-cast

Share

S1 #1 Engagement

More Episodes

VIEW ALL

Series 2 Trailer

S1 #7 The Global Movement to Eliminate Viral Hepatitis

S1 #6 UK in Focus: Collaborate to Eliminate